טוען...
Comparison of ramosetron with ondansetron for the prevention of post-operative nausea and vomiting in high-risk patients
BACKGROUND AND AIMS: Post-operative nausea and vomiting (PONV) has an 80% incidence in high-risk patients. This is despite the availability of several antiemetic drugs. Selective 5-hydroxytryptamine type 3 (5-HT(3)) receptor antagonists are considered first-line for prophylaxis, ondansetron being th...
שמור ב:
| הוצא לאור ב: | Indian J Anaesth |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4408650/ https://ncbi.nlm.nih.gov/pubmed/25937648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5049.154999 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|